• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

X连锁免疫缺陷病的进展

Advances in X-linked immunodeficiency diseases.

作者信息

Ochs H D, Aruffo A

机构信息

Department of Pediatrics, University of Washington School of Medicine, Seattle 98195.

出版信息

Curr Opin Pediatr. 1993 Dec;5(6):684-91. doi: 10.1097/00008480-199312000-00008.

DOI:10.1097/00008480-199312000-00008
PMID:7907259
Abstract

The molecular basis for three well-defined X-linked diseases has recently been identified. In X-linked agammaglobulinemia, the gene encoding a novel cytoplasmic tyrosine kinase (btk) expressed by B cells is defective. This B-cell-specific kinase belongs to a new subfamily of tyrosine kinases. The molecular defect in X-linked hyper IgM affects the gene encoding the CD40 ligand (CD40L, gp39) on T cells. This protein binds to its natural receptor, CD40, expressed constitutively by B cells. The ligand-receptor interaction initiates B-cell proliferation and isotype switching. The molecular defect in X-linked severe combined immunodeficiency disease has been assigned to the gene encoding the gamma chain of the interleukin-2 receptor (IL-2R gamma), which is constitutively expressed by T cells and is involved in the formation of high and intermediate affinity IL-2R complexes. IL-2R-gamma is responsible for the failure of X-linked severe combined immunodeficiency disease T and B lymphocytes to respond to IL-2-dependent signals.

摘要

最近已确定了三种明确的X连锁疾病的分子基础。在X连锁无丙种球蛋白血症中,B细胞表达的一种新型细胞质酪氨酸激酶(btk)的编码基因存在缺陷。这种B细胞特异性激酶属于酪氨酸激酶的一个新亚家族。X连锁高IgM血症中的分子缺陷影响T细胞上编码CD40配体(CD40L,gp39)的基因。该蛋白与其天然受体CD40结合,CD40由B细胞组成性表达。配体-受体相互作用启动B细胞增殖和同种型转换。X连锁严重联合免疫缺陷病中的分子缺陷已归因于编码白细胞介素-2受体(IL-2Rγ)γ链的基因,该基因由T细胞组成性表达,并参与高亲和力和中等亲和力IL-2R复合物的形成。IL-2R-γ导致X连锁严重联合免疫缺陷病的T和B淋巴细胞无法对IL-2依赖性信号作出反应。

相似文献

1
Advances in X-linked immunodeficiency diseases.X连锁免疫缺陷病的进展
Curr Opin Pediatr. 1993 Dec;5(6):684-91. doi: 10.1097/00008480-199312000-00008.
2
The molecular basis of X-linked agammaglobulinemia, hyper-IgM syndrome, and severe combined immunodeficiency in humans.人类X连锁无丙种球蛋白血症、高IgM综合征和重症联合免疫缺陷的分子基础。
Curr Opin Hematol. 1994 Jan;1(1):12-8.
3
X-linked immunodeficiencies.
Curr Opin Genet Dev. 1994 Jun;4(3):401-6. doi: 10.1016/0959-437x(94)90028-0.
4
[Molecular genetics of X-linked primary immunodeficiencies: advances in diagnosis and prevention].[X连锁原发性免疫缺陷病的分子遗传学:诊断与预防进展]
Ann Ital Med Int. 1996 Jul-Sep;11(3):180-6.
5
Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)".T细胞上CD40配体的表达缺陷会导致“X连锁高免疫球蛋白M血症(HIGM1)”。
Immunol Rev. 1994 Apr;138:39-59. doi: 10.1111/j.1600-065x.1994.tb00846.x.
6
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.X连锁高IgM综合征患者活化T细胞中的CD40配体gp39存在缺陷。
Cell. 1993 Jan 29;72(2):291-300. doi: 10.1016/0092-8674(93)90668-g.
7
CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers.伴有正常或升高水平 IgM 的无丙种球蛋白血症(HIM)中的 CD40 配体(CD40L)表达及 B 细胞功能。该疾病的 X 连锁、常染色体隐性及非 X 连锁形式的比较,以及携带者。
J Immunol. 1994 Oct 1;153(7):3295-306.
8
CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.X连锁高IgM免疫缺陷中的CD40配体突变
Nature. 1993 Feb 11;361(6412):541-3. doi: 10.1038/361541a0.
9
Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM.X染色体连锁的免疫球蛋白缺陷伴IgM正常或升高时CD40配体的表达缺陷。
Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2170-3. doi: 10.1073/pnas.90.6.2170.
10
Molecular and genetic basis of X-linked immunodeficiency disorders.X连锁免疫缺陷疾病的分子与遗传基础。
J Clin Immunol. 1994 Mar;14(2):81-9. doi: 10.1007/BF01541340.